Micra Transcatheter Pacing System Post-Approval Registry
← catalyst calendarNCT02536118 · readout ≤ 254 d
Sponsored by Medtronic (industry) · MDT — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
3,100actual
Sites
156
Countries
Belgium, Canada, Czechia +21
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Jul 2015 | actual | When the study began enrolling |
| Primary completion | Apr 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Apr 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2015-08-31 | estimated | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-02-04 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Bradycardia
Intervention
- Device: Micra Transcatheter Pacing System — also filed as Micra, Micra TPS
Primary outcomes
what the primary-completion date above is the date OFAcute complication rate
measured 30-days
Long-term complication free survival
measured 9 years
Publications
- PMID 35025987 — linked by the registry
- PMID 34757189 — linked by the registry
- PMID 33428248 — linked by the registry
- PMID 32763431 — linked by the registry
- PMID 30103071 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · MDT's whole pipeline · Catalyst calendar · Every registered study · What changed